|
C2230
- 英文名称：C2230
- 品牌：WYTSCI
- 产地：进口
- 型号：1MG
- 货号：WT-AY-B11473
- cas：882243-88-1
- 价格： ￥1/mg
- 发布日期： 2025-04-10
- 更新日期： 2025-05-23
产品详请
| 产地 | 进口 |
| 品牌 | WYTSCI |
| 货号 | WT-AY-B11473 |
| 用途 | 科研检测 |
| 英文名称 | C2230 |
| 包装规格 | 1MG |
| CAS编号 | 882243-88-1 |
| 别名 | C2230 |
| 纯度 | 98+% |
| 分子式 | |
| 是否进口 | 是 |
纯度:>98% by TLC,;NMR (Conforms)
分子式:C19H31NO3
分子量:321.46
溶剂:DMSO (>100 mg/ml)
性状:White to off-white waxy solid
存储:-20°C
Activity (short version):Cav2.2 channel blocker
Function / Pharmacology:C2230 is a novel Cav2.2 channel blocker (IC50 = 1.3 μM @ -50 mV; 10.2 μM @ -80 mV) with a unique binding mode (no GPCR-mediated inhibition). It displays preferential binding to the inactive state of the channel. C2230 is active in both rat and human DRG neurons. Active in rat models of neuropathic pain and mouse models of osteoarthritis. C2230 does not affect somatosensation or motor and cardiac function.
分子式:C19H31NO3
分子量:321.46
溶剂:DMSO (>100 mg/ml)
性状:White to off-white waxy solid
存储:-20°C
Activity (short version):Cav2.2 channel blocker
Function / Pharmacology:C2230 is a novel Cav2.2 channel blocker (IC50 = 1.3 μM @ -50 mV; 10.2 μM @ -80 mV) with a unique binding mode (no GPCR-mediated inhibition). It displays preferential binding to the inactive state of the channel. C2230 is active in both rat and human DRG neurons. Active in rat models of neuropathic pain and mouse models of osteoarthritis. C2230 does not affect somatosensation or motor and cardiac function.
